Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000206180 | SCV000261981 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000431594 | SCV000528962 | benign | not specified | 2017-11-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000431594 | SCV000711806 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Asn1786Asp in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 3.54% (234/6614) of Finnish chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs45608038). |
Personalized Diabetes Medicine Program, |
RCV001172522 | SCV001335575 | benign | Monogenic diabetes | 2018-10-26 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL =0.006 + 9 predictors), BA1 (1.5% MAF in gnomAD, 3.5 % in gnomAD European Finnish population), BS2 (60 homozygotes in gnomAD)= benign |
Ambry Genetics | RCV002345743 | SCV002641610 | benign | Cardiovascular phenotype | 2019-01-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000206180 | SCV002797360 | likely benign | Alstrom syndrome | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001795340 | SCV004011178 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BS1, BS2 |
ARUP Laboratories, |
RCV000206180 | SCV004563046 | benign | Alstrom syndrome | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000431594 | SCV001921842 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000431594 | SCV001931456 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000431594 | SCV001953104 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795340 | SCV002036491 | likely benign | not provided | no assertion criteria provided | clinical testing |